Prevalence, Dynamics and Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Newly Diagnosed Cancer Patients

被引：0

作者：

Perez Gonzalez, Ana ^{[1
]}

Pellin Jou, Claudia ^{[1
]}

Palomo, Laura ^{[1
]}

Navarro Garces, Victor ^{[2
]}

Calvete, Oriol ^{[3
]}

Zamora, Esther ^{[4
]}

Saoudi Gonzalez, Nadia ^{[4
]}

Farinas-Madrid, Lorena ^{[4
]}

David Assaf, Juan ^{[4
]}

Eugenia Rivero, Maria ^{[5
]}

Molero Yordi, Antonieta ^{[1
]}

Salamero, Olga ^{[1
]}

Jerez, Andres ^{[1
]}

Garrido Paniagua, Sara ^{[1
]}

Sola, Maria ^{[1
]}

Novoa Jauregui, Sandra ^{[1
]}

Jimenez, Moraima ^{[1
]}

Beas, Francisco ^{[1
]}

Sole, Francesc ^{[3
]}

Diez-Campelo, Maria ^{[6
]}

Alfonso Pierola, Ana ^{[7
]}

Bosch, Francesc ^{[1
]}

Montoro, Julia ^{[1
]}

Valcarcel Ferreiras, David ^{[1
]}

机构：

[1] Univ Autonoma Barcelona UAB, Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Expt Hematol Unit, Barcelona, Spain

[2] Vall Hebron Inst Oncol VHIO, Oncol Data Sci ODysSey Grp, Barcelona, Spain

[3] Univ Autonoma Barcelona, Josep Carreras Leukaemia Res Inst, Myelodysplast Syndromes Res Grp, ICO Hosp Germans Trias & Pujol, Badalona, Spain

[4] Univ Autonoma Barcelona UAB, Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

[5] Univ Lleida, Univ Hosp Arnau Vilanova, Dept Hematol, Lleida, Spain

[6] Salamanca IBSAL Univ Hosp, Dept Hematol, Salamanca, Spain

[7] Univ Navarra, Dept Oncol Hematol,IDISNA, Clin Univ Navarra,Ctr Invest Med Aplicada CIMA, CIBERONC,Ctr Invest Biomed Red Canc, Navarra, Spain

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-189503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[31] Clinical features of AL amyloidosis patients harboring clonal hematopoiesis of indeterminate potential
Lopedote, Paolo
Evans, Benjamin
Marchetti, Alfredo
Chen, Tianzeng
Moscvin, Maria
Boullt, Samuel
Bolli, Niccolo'
Bianchi, Giada
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S49 - S50
[32] Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19
Schenz, Judith
Rump, Katharina
Siegler, Benedikt Hermann
Hemmerling, Inga
Rahmel, Tim
Thon, Jan N.
Nowak, Hartmuth
Fischer, Dania
Hafner, Anna
Tichy, Lucas
Bomans, Katharina
Meggendorfer, Manja
Koos, Bjoern
von Groote, Thilo
Zarbock, Alexander
Fiedler, Mascha O.
Zemva, Johanna
Larmann, Jan
Merle, Uta
Adamzik, Michael
Mueller-Tidow, Carsten
Haferlach, Torsten
Leuschner, Florian
Weigand, Markus A.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[33] Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations
Mangaonkar, Abhishek A.
Patnaik, Mrinal M.
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (06) : 951 - 964
[34] Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma
Mouhieddine, Tarek H.
Nzerem, Chidimma
Redd, Robert
Dunford, Andrew
Leventhal, Matthew
Sklavenitis-Pistofidis, Romanos
Tahri, Sabrin
El-Khoury, Habib
Steensma, David P.
Ebert, Benjamin L.
Soiffer, Robert J.
Keats, Jonathan J.
Mehr, Shaadi
Auclair, Daniel
Ghobrial, Irene M.
Sperling, Adam S.
Stewart, Chip
Getz, Gad
CANCER RESEARCH COMMUNICATIONS, 2023, 3 (12): : 2560 - 2571
[35] Clonal Hematopoiesis Prevalence Increases throughout Treatment of Newly Diagnosed Multiple Myeloma Patients
Mouhieddine, Tarek H.
Nzerem, Chidimma
Redd, Robert A.
Dunford, Andrew
Leventhal, Matthew Joseph
Sklavenitis-Pistofidis, Romanos
Tahri, Sabrin
El-Khoury, Habib
Steensma, David P.
Ebert, Benjamin L.
Soiffer, Robert J.
Keats, Jonathan J.
Mehr, Shaadi
Auclair, Daniel
Sperling, Adam S.
Stewart, Chip
Getz, Gad
Ghobrial, Irene M.
BLOOD, 2021, 138
[36] Authors' Reply to Letter to the Editor: Significance of Clonal Hematopoiesis of Indeterminate Potential
Usha, Lydia
Burgess, Kelly
Klapko, Oleksandra
Buckingham, Lela
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1033 - 1033
[37] Clonal Hematopoiesis of Indeterminate Potential (CHIP) is an Independent Risk Factor for Cardiomyopathy in Patients With Solid Malignancy
Martinez, Carlos F. Matute
Jayakrishnan, Ritujith
Guajardo, Ana Ferrigno
Leveille, Etienne
Lin, Derrick
Im, Yunju
Christofides, Anthos
Chen, Nathan
Baldassarre, Lauren A.
VanOudenhove, Jennifer
CIRCULATION, 2023, 148
[38] MYOCARDIAL IMPACT OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) SECRETOMES IN CARDIO-ONCOLOGY PATIENTS
Kwan, Jennifer
Vanoudenhove, Jennifer
Halder, Saiti
Biancon, Giulia
Jain, Kanika
Chakraborty, Raja
Lustberg, Maryam
Pusztai, Lajos
Campbell, Stuart
Zhao, Hongyu
Halene, Stephanie
Hwa, John
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1912 - 1912
[39] Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Gagnon, Marie-France
Tian, Shulan
Geyer, Susan
Sharma, Neeraj
Vachon, Celine M.
Kusne, Yael
Bergsagel, P. Leif
Stewart, A. Keith
Rajkumar, S. Vincent
Kumar, Shaji
Ailawadhi, Sikander
Baughn, Linda B.
BLOOD CANCER JOURNAL, 2022, 12 (07)
[40] Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms
Marie-France Gagnon
Shulan Tian
Susan Geyer
Neeraj Sharma
Celine M. Vachon
Yael Kusne
P. Leif Bergsagel
A. Keith Stewart
S. Vincent Rajkumar
Shaji Kumar
Sikander Ailawadhi
Linda B. Baughn
Blood Cancer Journal, 12

← 1 2 3 4 5 →